Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (TSC-007)

  • Details

ClinicalTrials.gov ID: NCT05103358
Diagnosis Type: Solid Tumors
USOR Number: 22052

  • Practice Details

11750 W 2nd Place, Suite 160
Lakewood, CO 80228
P: (303) 430-2700

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (TSC-007)

  • Details

ClinicalTrials.gov ID: NCT05103358
Diagnosis Type: Solid Tumors
USOR Number: 22052

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, CO 80113
P: (303) 740-8200

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (TSC-007)

  • Details

ClinicalTrials.gov ID: NCT05103358
Diagnosis Type: Solid Tumors
USOR Number: 22052

  • Practice Details

4700 E Hale Parkway, Suite 400
Denver, CO 80220
P: (303) 321-0302

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (TSC-007)

  • Details

ClinicalTrials.gov ID: NCT05103358
Diagnosis Type: Solid Tumors
USOR Number: 22052

  • Practice Details

1800 Williams St, Suite 200
Denver, CO 80218
P: (303) 388-4876

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (TSC-007)

  • Details

ClinicalTrials.gov ID: NCT05103358
Diagnosis Type: Solid Tumors
USOR Number: 22052

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, CO 80907
P: (719) 577-2555

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Centennial

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (TSC-007)

  • Details

ClinicalTrials.gov ID: NCT05103358
Diagnosis Type: Solid Tumors
USOR Number: 22052

  • Practice Details

14000 E. Arapahoe Rd.
Centennial, CO 80112
P: 303-805-7744

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (TSC-007)

  • Details

ClinicalTrials.gov ID: NCT05103358
Diagnosis Type: Solid Tumors
USOR Number: 22052

  • Practice Details

4715 Arapahoe Avenue
Boulder, CO 80303
P: (303) 385-2000

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Aurora

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (TSC-007)

  • Details

ClinicalTrials.gov ID: NCT05103358
Diagnosis Type: Solid Tumors
USOR Number: 22052

  • Practice Details

1700 S Potomac Street
Aurora, CO 80012
P: (303) 418-7600

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

20190135: A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Sotorasib in Combination with Pembrolizumab in Subjects with Advanced Non-small Cell Lung Cancer (NSCLC) With KRAS p.G12C Mutation (CodeBreak 101 Subprotocol I)

  • Details

ClinicalTrials.gov ID: NCT04185883
Diagnosis Type: Lung Cancer
USOR Number: 20388

  • Practice Details

1800 Williams St, Suite 200
Denver, CO 80218
P: (303) 388-4876

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lone Tree

20190135: A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Sotorasib in Combination with Pembrolizumab in Subjects with Advanced Non-small Cell Lung Cancer (NSCLC) With KRAS p.G12C Mutation (CodeBreak 101 Subprotocol I)

  • Details

ClinicalTrials.gov ID: NCT04185883
Diagnosis Type: Lung Cancer
USOR Number: 20388

  • Practice Details

10107 RidgeGate Parkway, Suite 200
Lone Tree, CO 80124
P: (303) 925-0700

More Details View Practice Page